» Articles » PMID: 31329932

Mechanism of Allosteric Activation of Human MRNA Cap Methyltransferase (RNMT) by RAM: Insights from Accelerated Molecular Dynamics Simulations

Overview
Specialty Biochemistry
Date 2019 Jul 23
PMID 31329932
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The RNA guanine-N7 methyltransferase (RNMT) in complex with RNMT-activating miniprotein (RAM) catalyses the formation of a N7-methylated guanosine cap structure on the 5' end of nascent RNA polymerase II transcripts. The mRNA cap protects the primary transcript from exonucleases and recruits cap-binding complexes that mediate RNA processing, export and translation. By using microsecond standard and accelerated molecular dynamics simulations, we provide for the first time a detailed molecular mechanism of allosteric regulation of RNMT by RAM. We show that RAM selects the RNMT active site conformations that are optimal for binding of substrates (AdoMet and the cap), thus enhancing their affinity. Furthermore, our results strongly suggest the likely scenario in which the cap binding promotes the subsequent AdoMet binding, consistent with the previously suggested cooperative binding model. By employing the network community analyses, we revealed the underlying long-range allosteric networks and paths that are crucial for allosteric regulation by RAM. Our findings complement and explain previous experimental data on RNMT activity. Moreover, this study provides the most complete description of the cap and AdoMet binding poses and interactions within the enzyme's active site. This information is critical for the drug discovery efforts that consider RNMT as a promising anti-cancer target.

Citing Articles

Deciphering the secret codes in N-methylguanosine modification: Context-dependent function of methyltransferase-like 1 in human diseases.

Fang H, He J, Du D, Wang X, Xu X, Lu L Clin Transl Med. 2025; 15(2):e70240.

PMID: 39979979 PMC: 11842222. DOI: 10.1002/ctm2.70240.


The Role of mRNA Modifications in Bone Diseases.

Li Z, Meng K, Lan S, Ren Z, Lai Z, Ao X Int J Biol Sci. 2025; 21(3):1065-1080.

PMID: 39897026 PMC: 11781163. DOI: 10.7150/ijbs.104460.


N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential.

Wu Q, Fu X, Liu G, He X, Li Y, Ou C J Hematol Oncol. 2025; 18(1):12.

PMID: 39881381 PMC: 11780989. DOI: 10.1186/s13045-025-01665-7.


RNA methylation and breast cancer: insights into m6A, m7G and m5C.

Dai Y, Zhao S, Chen H, Yu W, Fu Z, Cui Y Mol Biol Rep. 2024; 52(1):27.

PMID: 39611867 DOI: 10.1007/s11033-024-10138-y.


A review of current developments in RNA modifications in lung cancer.

Zhang S, Liu Y, Liu K, Hu X, Gu X Cancer Cell Int. 2024; 24(1):347.

PMID: 39456034 PMC: 11515118. DOI: 10.1186/s12935-024-03528-6.


References
1.
Miao Y, Nichols S, McCammon J . Free energy landscape of G-protein coupled receptors, explored by accelerated molecular dynamics. Phys Chem Chem Phys. 2014; 16(14):6398-406. PMC: 3960983. DOI: 10.1039/c3cp53962h. View

2.
Wang J, Wolf R, Caldwell J, Kollman P, Case D . Development and testing of a general amber force field. J Comput Chem. 2004; 25(9):1157-74. DOI: 10.1002/jcc.20035. View

3.
Sethi A, Eargle J, Black A, Luthey-Schulten Z . Dynamical networks in tRNA:protein complexes. Proc Natl Acad Sci U S A. 2009; 106(16):6620-5. PMC: 2672494. DOI: 10.1073/pnas.0810961106. View

4.
Martin J, McMillan F . SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold. Curr Opin Struct Biol. 2002; 12(6):783-93. DOI: 10.1016/s0959-440x(02)00391-3. View

5.
Grasso L, Suska O, Davidson L, Gonatopoulos-Pournatzis T, Williamson R, Wasmus L . mRNA Cap Methylation in Pluripotency and Differentiation. Cell Rep. 2016; 16(5):1352-1365. PMC: 4977272. DOI: 10.1016/j.celrep.2016.06.089. View